Market Cap: $45.42B
Market Cap: $45.42B
Open
$33.00
Prev. Close
$37.00
High
$33.00
Low
$33.00
Teva Pharmaceutical Industries Limited operates as a global pharmaceutical enterprise, engaging in the research, production, marketing, and distribution of generic medications, specialized pharmaceutical products, and biopharmaceuticals. The company's reach extends across North America, Europe, and various other international markets.
Teva Pharmaceutical Industries Limited trades on the Other OTC under the ticker TEVJF, priced in USD.
Teva Pharmaceutical Industries Limited has a market capitalisation of $45.42B, based on its latest share price.
TEVJF trades at 84.74 times its trailing 12-month earnings.
Over the past 52 weeks TEVJF has traded between $14.32 and $39.70.
No. Teva Pharmaceutical Industries Limited does not currently pay a dividend.
Profitable, with a net margin of 3.0% over the last 12 months.
The analyst consensus rating for TEVJF is Hold.
Richard D. Francis is the CEO of Teva Pharmaceutical Industries Limited, which is headquartered in Tel Aviv.
Generated automatically from reported financial data. General information only, not financial advice.